Lv31
230 积分 2022-05-29 加入
Parkinson disease therapy: current strategies and future research priorities
8天前
已完结
Teclistamab-Induced Remission in Refractory Systemic Lupus Erythematosus
11天前
已完结
BCMA-Targeted T-Cell–Engager Therapy for Autoimmune Disease
11天前
已完结
TL1A inhibition for inflammatory bowel disease treatment: From inflammation to fibrosis
18天前
已完结
CD28 co-stimulation: novel insights and applications in cancer immunotherapy
2个月前
已完结
Navigating the complexities of drug development for inflammatory bowel disease
3个月前
已完结
Discovery of a novel exceptionally potent and orally active Nur77 ligand NB1 with a distinct binding mode for cancer therapy
3个月前
已完结
Reducing affinity as a strategy to boost immunomodulatory antibody agonism
4个月前
已完结
CD22-targeted CD28 bispecific antibody enhances antitumor efficacy of odronextamab in refractory diffuse large B cell lymphoma models
4个月前
已完结
Generation of a novel fully human non-superagonistic anti-CD28 antibody with efficient and safe T-cell co-stimulation properties
4个月前
已完结
皖公网安备34019202002308
